Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3).SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded related topics to the page: Type 2 diabetes and MedlinePlus Genetics. This aligns the page with the study's subject and improves navigation to related information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision note (v3.4.3) was added, and several related topics including Type 2 diabetes, MedlinePlus Genetics, and the previous revision reference (v3.4.2) were removed.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded related topics MedlinePlus Genetics and Type 2 diabetes for additional context, without altering the study's core information.SummaryDifference0.1%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.